Publications 2023

Dueland S, Smedman TM, Syversveen T, Grut H, Hagness M, Line PD (2023)
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
JAMA Surg, 158 (9), e232932
DOI 10.1001/jamasurg.2023.2932, PubMed 37494056

Publications 2022

Dueland S, Smedman TM, Grut H, Syversveen T, Jørgensen LH, Line PD (2022)
PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
Cancers (Basel), 14 (20)
DOI 10.3390/cancers14205042, PubMed 36291826

Smedman TM, Guren TK, Tveit KM, Thomsen M, Andersen MH, Line PD, Dueland S (2022)
Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
Transpl Int, 35, 10404
DOI 10.3389/ti.2022.10404, PubMed 35707633

Publications 2021

Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl Int, 34 (11), 2205-2213
DOI 10.1111/tri.13995, PubMed 34792825

Publications 2020

Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
BJS Open, 4 (3), 467-477
DOI 10.1002/bjs5.50278, PubMed 32333527

Publications 2019

Smedman TM, Guren TK, Line PD, Dueland S (2019)
Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study
Transpl Int, 32 (11), 1144-1150
DOI 10.1111/tri.13471, PubMed 31209941

Publications 2018

Smedman TM, Line PD, Guren TK, Dueland S (2018)
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
Acta Oncol, 57 (10), 1414-1418
DOI 10.1080/0284186X.2018.1479069, PubMed 29912605